InsidersTradesSigma
Total declarations
Company
▲ Purchases (11 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
11
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Rowe Michael M, Chief Operating Officer. Director active across 1 company, notably Eyenovia, INC.. Aggregated, 12 filings have been recorded. Split: 11 buys · 0 sell. Total volume traded: €91k. Activity tracked since 27 May 2021. The latest transaction was disclosed on 28 August 2024 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations12 total
27,071 shares@ US$0.5210.9% of flowCommon Stock, par value $0.0001SEC:0001104659-24-094160:0
Ideal exit: 25 May 2025 (T+270)
50,000 shares@ US$0.5722.0% of flowCommon Stock, par value $0.0001SEC:0001104659-24-093231:0
Ideal exit: 23 May 2025 (T+270)
4,890 shares@ US$1.365.3% of flowCommon Stock, par value $.0001SEC:0001104659-23-123637:0
Ideal exit: 30 Aug 2024 (T+270)
1,137 shares@ US$1.752.6% of flowCommon Stock, par value $.0001SEC:0001104659-23-101986:0
Ideal exit: 11 Jun 2024 (T+270)
10,000 shares@ US$2.7221.4% of flowCommon Stock, par value $.0001SEC:0001104659-23-054671:0
10,000 shares@ US$1.5412.5% of flowCommon Stock, par value $.0001SEC:0001415889-23-000171:0
Ideal exit: 26 Sept 2023 (T+270)
1,200 shares@ US$4.1414.0% of flowCommon Stock, par value $.0001SEC:0001415889-21-004985:0
Ideal exit: 24 Jul 2022 (T+270)
1,200 shares@ US$4.143.7% of flowCommon Stock, par value $.0001SEC:0001415889-21-004985
Ideal exit: 24 Jul 2022 (T+270)
1,500 shares@ US$4.4018.3% of flowCommon Stock, par value $.0001SEC:0001638599-21-000708:0
Ideal exit: 10 Jun 2022 (T+270)
1,500 shares@ US$4.404.8% of flowCommon Stock, par value $.0001SEC:0001638599-21-000708
Ideal exit: 10 Jun 2022 (T+270)
1,400 shares@ US$4.7117.7% of flowCommon Stock, par value $.0001SEC:0001638599-21-000472:0
Ideal exit: 21 Feb 2022 (T+270)
1,400 shares@ US$4.7117.7% of flowCommon Stock, par value $.0001SEC:0001638599-21-000472
Ideal exit: 21 Feb 2022 (T+270)
12 of 12 declarations
About Rowe Michael M
Michael M. Rowe is the Chief Operating Officer at Eyenovia, Inc. He oversees the daily operations of the company, ensuring efficiency and achievement of strategic objectives. His expertise in the biopharmaceutical sector is crucial for developing new therapies.
